Share This Article:

Migraine History and Breast Cancer Risk: A Systematic Review and Meta-Analysis

Abstract Full-Text HTML XML Download Download as PDF (Size:1240KB) PP. 63-70
DOI: 10.4236/abcr.2015.43007    3,068 Downloads   3,744 Views   Citations

ABSTRACT

Objective: The relationship between migraine and breast cancer risk has been reported inconsistently across different epidemiological studies. This meta-analysis was performed to explore the overall effect of migraine on breast cancer risk. Method: An electronic search of different major databases was conducted, including PubMed, Scopus, ScienceDirect, and the Cochrane library until February 1st, 2015. Of 652 retrieved studies, six population-based studies including two cohort studies with 130,812 and four case-control studies with 14,396 people were included in the analysis. Results: There was an inverse relationship between migraine and breast cancer risk (OR = 0.77; 95% CI: 0.64, 0.92). Conclusion: The results of this meta-analysis showed that women with migraine history have a decreased risk of breast cancer. Further biological studies are needed to address the association.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Rezaeian, S. , Veisani, Y. , Ghorbani, M. , Delpisheh, A. and Abbastabar, H. (2015) Migraine History and Breast Cancer Risk: A Systematic Review and Meta-Analysis. Advances in Breast Cancer Research, 4, 63-70. doi: 10.4236/abcr.2015.43007.

References

[1] Fernández-de-Las-Penas, C., Palacios-Cena, D., Salom-Moreno, J., López-de-Andres, A., Hernández-Barrera, V., Jiménez-Trujillo, I., et al. (2014) Has the Prevalence of Migraine Changed over the Last Decade (2003-2012)? A Spanish Population-Based Survey. PLoS ONE, 9, e110530.
http://dx.doi.org/10.1371/journal.pone.0110530
[2] Smitherman, T.A., Burch, R., Sheikh, H. and Loder, E. (2013) The Prevalence, Impact, and Treatment of Migraine and Severe Headaches in the United States: A Review of Statistics from National Surveillance Studies. Headache: The Journal of Head and Face Pain, 53, 427-436.
http://dx.doi.org/10.1111/head.12074
[3] Ramage-Morin, P.L. and Gilmour, H. (2014) Prevalence of Migraine in the Canadian Household Population. Health Reports, 25, 10-16.
[4] Siegel, R., Ma, J., Zou, Z. and Jemal, A. (2014) Cancer Statistics. CA: A Cancer Journal for Clinicians, 64, 9-29.
http://dx.doi.org/10.3322/caac.21208
[5] WHO (2006) Guidelines for Management of Breast Cancer. Egypt.
[6] McPherson, K., Steel, C.M. and Dixon, J.M. (2000) ABC of Breast Diseases. Breast Cancer-Epidemiology, Risk Factors, and Genetics. British Medical Journal, 321, 624-628.
http://dx.doi.org/10.1136/bmj.321.7261.624
[7] Rist, P.M., Diener, H.C., Kurth, T. and Schürks, M. (2011) Migraine, Migraine Aura, and Cervical Artery Dissection: A Systematic Review and Meta-Analysis. Cephalalgia, 31, 886-896.
http://dx.doi.org/10.1177/0333102411401634
[8] Etminan, M., Takkouche, B., Isorna, F.C. and Samii, A. (2005) Risk of Ischaemic Stroke in People with Migraine: Systematic Review and Meta-Analysis of Observational Studies. British Medical Journal, 330, 63.
http://dx.doi.org/10.1136/bmj.38302.504063.8F
[9] Schürks, M., Rist, P.M., Shapiro, R.E. and Kurth, T. (2011) Migraine and Mortality: A Systematic Review and Meta-Analysis. Cephalalgia, 31, 1301-1314.
http://dx.doi.org/10.1177/0333102411415879
[10] Li, C.I., Mathes, R.W., Bluhm, E.C., Caan, B., Cavanagh, M.F., Chlebowski, R.T., et al. (2010) Migraine History and Breast Cancer Risk among Postmenopausal Women. Journal of Clinical Oncology, 28, 1005-1010.
http://dx.doi.org/10.1200/JCO.2009.25.0423
[11] Li, C.I., Mathes, R.W., Malone, K.E., Daling, J.R., Bernstein, L., Marchbanks, P.A., et al. (2009) Relationship between Migraine History and Breast Cancer Risk among Premenopausal and Postmenopausal Women. Cancer Epidemiology, Biomarkers & Prevention, 18, 2030-2034.
http://dx.doi.org/10.1158/1055-9965.EPI-09-0291
[12] Lowry, S.J., Malone, K.E., Cushing-Haugen, K.L. and Li, C.I. (2014) The Risk of Breast Cancer Associated with Specific Patterns of Migraine History. Cancer Causes & Control, 25, 1707-1715.
http://dx.doi.org/10.1007/s10552-014-0479-y
[13] Mathes, R.W., Malone, K.E., Daling, J.R., Davis, S., Lucas, S.M., Porter, P.L., et al. (2008) Migraine in Post-Menopausal Women and the Risk of Invasive Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention, 17, 3116-3122. http://dx.doi.org/10.1158/1055-9965.EPI-08-0527
[14] Ghorbani, A., Moradi, A., Gookizadeh, A., Jokar, S. and Sonbolestan, S.A. (2015) Evaluation of Relationship between Breast Cancer and Migraine. Advanced Biomedical Research, 4, 14. http://dx.doi.org/10.4103/2277-9175.148297
[15] Winter, A.C., Rexrode, K.M., Lee, I.M., Buring, J.E., Tamimi, R.M. and Kurth, T. (2013) Migraine and Subsequent Risk of Breast Cancer: A Prospective Cohort Study. Cancer Causes & Control, 24, 81-89.
http://dx.doi.org/10.1007/s10552-012-0092-x
[16] Phipps, A.I., Anderson, G.L., Cochrane, B.B., Li, C.I., Wactawski-Wende, J., Ho, G.Y., et al. (2012) Migraine History, Nonsteroidal Anti-Inflammatory Drug Use, and Risk of Postmenopausal Endometrial Cancer. Hormones and Cancer, 3, 240-248.
[17] von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gotzsche, P.C., Vandenbroucke, J.P., et al. (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. British Medical Journal, 335, 806-808.
http://dx.doi.org/10.1136/bmj.39335.541782.AD
[18] Borenstein, M., Hedges, L.V., Higgins, J.P.T. and Rothstein, H.R. (2009) Introduction to Meta-Analysis. John Wiley & Sons, Hoboken.
http://dx.doi.org/10.1002/9780470743386
[19] Egger, M., Davey, S.G., Schneider, M. and Minder, C. (1997) Bias in Meta-Analysis Detected by a Simple, Graphical Test. British Medical Journal, 315, 629-634.
http://dx.doi.org/10.1136/bmj.315.7109.629
[20] Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P., et al. (2009) The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies that Evaluate Healthcare Interventions: Explanation and Elaboration. British Medical Journal, 339, b2700.
http://dx.doi.org/10.1136/bmj.b2700
[21] Brandes, J.L. (2006) The Influence of Estrogen on Migraine: A Systematic Review. The Journal of the American Medical Association, 295, 1824-1830.
http://dx.doi.org/10.1001/jama.295.15.1824
[22] Suzuki, R., Orsini, N., Saji, S., Key, T.J. and Wolk, A. (2009) Body Weight and Incidence of Breast Cancer Defined by Estrogen and Progesterone Receptor Status—A Meta-Analysis. International Journal of Cancer, 124, 698-712.
http://dx.doi.org/10.1002/ijc.23943
[23] Vrieling, A., Buck, K., Kaaks, R. and Chang-Claude, J. (2010) Adult Weight Gain in Relation to Breast Cancer Risk by Estrogen and Progesterone Receptor Status: A Meta-Analysis. Breast Cancer Research and Treatment, 123, 641-649.
http://dx.doi.org/10.1007/s10549-010-1116-4
[24] Althuis, M.D., Fergenbaum, J.H., Garcia-Closas, M., Brinton, L.A., Madigan, M.P. and Sherman, M.E. (2004) Etiology of Hormone Receptor-Defined Breast Cancer: A Systematic Review of the Literature. Cancer Epidemiology, Biomarkers & Prevention, 13, 1558-1568.
[25] Phipps, A.I., Malone, K.E., Porter, P.L., Daling, J.R. and Li, C.I. (2008) Body Size and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer in Postmenopausal Women. Cancer Epidemiology, Biomarkers & Prevention, 17, 2078-2086.
http://dx.doi.org/10.1158/1055-9965.EPI-08-0206
[26] Munsell, M.F., Sprague, B.L., Berry, D.A., Chisholm, G. and Trentham-Dietz, A. (2014) Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor Status. Epidemiologic Reviews, 36, 114-136.
http://dx.doi.org/10.1093/epirev/mxt010
[27] Rasmussen, B.K. (1995) Epidemiology of Migraine. Biomedicine & Pharmacotherapy, 49, 452-455.
http://dx.doi.org/10.1016/0753-3322(96)82689-8

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.